Table 1.
Cohort demographics
| Metric | Total | TgAb− | TgAb+ | p-values |
|---|---|---|---|---|
| N=247 | N=213 | N=34 | ||
| Sex | 77.3% women, 22.7% men | 75.6% women 24.4% men |
85.3%women, 14.7% men | 0.28 |
| Age (years) | 45.7 ± 1.0 years | 46.2 ± 1.1 years | 43.0 ± 2.5 years | 0.28 |
| Tumor Size (cm) | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.3 | 0.99 |
| Histopathological Subtypes | 96.0% PTC | 95.3% PTC | 100% PTC | 0.37 |
| 4.0% FTC | 4.7% FTC | |||
| Autoimmune Thyroid Disease | 16.6% HT | 14.6% HT | 29.4% HT | 0.05 |
| 1.6% GD | 0.9% GD | 5.9% GD | 0.09 | |
| 18.2% Total | 15.5% Total | 35.3% Total | 0.01 | |
| Lymph Node Involvement | 8.9% | 8.5% | 11.8% | 0.75 |
| Extrathyroidal extension | 5.3% | 5.1% | 5.9% | 0.70 |
| Surgery Type | 76.2% Total | 75.1% Total | 85.3% Total | 0.28 |
| 23.8% Completion | 24.9% Completion | 14.7% Completion | ||